The Global Burden of Pleural Diseases

Erik Vakil; Niloofar Taghizadeh; Alain Tremblay

doi:10.1055/s-0043-1769614

Seminars in Respiratory and Critical Care Medicine, Inhaltsverzeichnis

Semin Respir Crit Care Med 2023; 44(04): 417-425
DOI: 10.1055/s-0043-1769614

Review Article

The Global Burden of Pleural Diseases

Erik Vakil

¹Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

,

Niloofar Taghizadeh

²Department of Emergency Medicine, Cumming School of Medicine, University of Calgary and Emergency Strategic Clinical Network, Alberta Health Services, Calgary, Alberta, Canada

,

Alain Tremblay

¹Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

› Institutsangaben

Abstract

Pleural diseases include a spectrum of disorders broadly categorized into pneumothorax and pleural effusion. They often cause pain, breathlessness, cough, and reduced quality of life. The global burden of diseases reflects regional differences in conditions and exposures associated with pleural disease, such as smoking, pneumonia, tuberculosis, asbestos, cancer, and organ failure. Disease burden in high-income countries is overrepresented given the availability of data and disease burden in lower-income countries is likely underestimated. In the United States, in 2016, there were 42,215 treat-and-discharge visits to the emergency room for pleural diseases and an additional 361,270 hospitalizations, resulting in a national cost of $10.1 billion.

Keywords

pleural diseases - pleural effusion - pneumothorax - tuberculous - mesothelioma

Volltext

Referenzen

References
1 Thomas R, Jenkins S, Eastwood PR, Lee YC, Singh B. Physiology of breathlessness associated with pleural effusions. Curr Opin Pulm Med 2015; 21 (04) 338-345
2 Light R. Pleural Diseases. 6th ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2013
3 Davies HE, Mishra EK, Kahan BC. et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA 2012; 307 (22) 2383-2389
4 Thomas R, Fysh ETH, Smith NA. et al. Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: The ample randomized clinical trial. JAMA 2017; 318 (19) 1903-1912
5 Sabur NF, Chee A, Stather DR. et al. The impact of tunneled pleural catheters on the quality of life of patients with malignant pleural effusions. Respiration 2013; 85 (01) 36-42
6 Gupta D, Hansell A, Nichols T, Duong T, Ayres JG, Strachan D. Epidemiology of pneumothorax in England. Thorax 2000; 55 (08) 666-671
7 Bobbio A, Dechartres A, Bouam S. et al. Epidemiology of spontaneous pneumothorax: gender-related differences. Thorax 2015; 70 (07) 653-658
8 Schnell J, Koryllos A, Lopez-Pastorini A, Lefering R, Stoelben E. Spontaneous Pneumothorax. Dtsch Arztebl Int 2017; 114 (44) 739-744
9 Kim D, Jung B, Jang BH, Chung SH, Lee YJ, Ha IH. Epidemiology and medical service use for spontaneous pneumothorax: a 12-year study using nationwide cohort data in Korea. BMJ Open 2019; 9 (10) e028624
10 Mummadi SR, Stoller JK, Lopez R, Kailasam K, Gillespie CT, Hahn PY. Epidemiology of adult pleural disease in the United States. Chest 2021; 160 (04) 1534-1551
11 Brown SGA, Ball EL, Perrin K. et al; PSP Investigators. Conservative versus interventional treatment for spontaneous pneumothorax. N Engl J Med 2020; 382 (05) 405-415
12 Walker SP, Bibby AC, Halford P, Stadon L, White P, Maskell NA. Recurrence rates in primary spontaneous pneumothorax: a systematic review and meta-analysis. Eur Respir J 2018; 52 (03) 1800864
13 Noppen M. Spontaneous pneumothorax: epidemiology, pathophysiology and cause. Eur Respir Rev 2010; 19 (117) 217-219
14 Onuki T, Ueda S, Yamaoka M. et al. Primary and secondary spontaneous pneumothorax: prevalence, clinical features, and in-hospital mortality. Can Respir J 2017; 2017: 6014967
15 MacDuff A, Arnold A, Harvey J. BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010. Thorax 2010; 65 (Suppl. 02) ii18-ii31
16 Brower RG, Lanken PN, MacIntyre N. et al; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351 (04) 327-336
17 Hsu CW, Sun SF. Iatrogenic pneumothorax related to mechanical ventilation. World J Crit Care Med 2014; 3 (01) 8-14
18 Chopra A, Al-Tarbsheh AH, Shah NJ. et al. Pneumothorax in critically ill patients with COVID-19 infection: incidence, clinical characteristics and outcomes in a case control multicenter study. Respir Med 2021; 184: 106464
19 Heerink WJ, de Bock GH, de Jonge GJ, Groen HJ, Vliegenthart R, Oudkerk M. Complication rates of CT-guided transthoracic lung biopsy: meta-analysis. Eur Radiol 2017; 27 (01) 138-148
20 Sainz Zuñiga PV, Vakil E, Molina S, Bassett Jr. RL, Ost DE. Sensitivity of radial endobronchial ultrasound-guided bronchoscopy for lung cancer in patients with peripheral pulmonary lesions: an updated meta-analysis. Chest 2020; 157 (04) 994-1011
21 Folch EE, Labarca G, Ospina-Delgado D. et al. Sensitivity and safety of electromagnetic navigation bronchoscopy for lung cancer diagnosis: systematic review and meta-analysis. Chest 2020; 158 (04) 1753-1769
22 Kusminsky RE. Complications of central venous catheterization. J Am Coll Surg 2007; 204 (04) 681-696
23 Gordon CE, Feller-Kopman D, Balk EM, Smetana GW. Pneumothorax following thoracentesis: a systematic review and meta-analysis. Arch Intern Med 2010; 170 (04) 332-339
24 van Rees JB, de Bie MK, Thijssen J, Borleffs CJW, Schalij MJ, van Erven L. Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. J Am Coll Cardiol 2011; 58 (10) 995-1000
25 Baumann MH, Noppen M. Pneumothorax. Respirology 2004; 9 (02) 157-164
26 Tran J, Haussner W, Shah K. Traumatic pneumothorax: a review of current diagnostic practices and evolving management. J Emerg Med 2021; 61 (05) 517-528
27 Dugan KC, Laxmanan B, Murgu S, Hogarth DK. Management of persistent air leaks. Chest 2017; 152 (02) 417-423
28 Bense L, Wiman LG, Jendteg S, Lindgren B. Economic costs of spontaneous pneumothorax. Chest 1991; 99 (01) 260-261
29 GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396 (10258): 1204-1222
30 Maskell NA, Batt S, Hedley EL, Davies CW, Gillespie SH, Davies RJ. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006; 174 (07) 817-823
31 World Health Organization. Global tuberculosis report 2019: report of the Director-General. 2019 Accessed May 4, 2023 at: https://www.who.int/publications/i/item/9789241565714
32 Lal C, Huggins JT, Sahn SA. Parasitic diseases of the pleura. Am J Med Sci 2013; 345 (05) 385-389
33 Finley C, Clifton J, Fitzgerald JM, Yee J. Empyema: an increasing concern in Canada. Can Respir J 2008; 15 (02) 85-89
34 Shen HN, Lu CL, Li CY. Epidemiology of pleural infections in Taiwan from 1997 through 2008. Respirology 2012; 17 (07) 1086-1093
35 Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax 2011; 66 (08) 663-668
36 Gupta I, Eid SM, Gillaspie EA, Broderick S, Shafiq M. Epidemiologic trends in pleural infection. a nationwide analysis. Ann Am Thorac Soc 2021; 18 (03) 452-459
37 Bobbio A, Bouam S, Frenkiel J. et al. Epidemiology and prognostic factors of pleural empyema. Thorax 2021; 76 (11) 1117-1123
38 Lehtomäki A, Nevalainen R, Ukkonen M, Nieminen J, Laurikka J, Khan J. Trends in the incidence, etiology, treatment, and outcomes of pleural infections in adults over a decade in a Finnish university hospital. Scand J Surg 2020; 109 (02) 127-132
39 Wong D, Yap E. Pleural infection in a New Zealand centre: high incidence in Pacific people and RAPID score as a prognostic tool. Intern Med J 2016; 46 (06) 703-709
40 Lisboa T, Waterer GW, Lee YC. Pleural infection: changing bacteriology and its implications. Respirology 2011; 16 (04) 598-603
41 Rahman NM, Maskell NA, West A. et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 2011; 365 (06) 518-526
42 Luengo-Fernandez R, Penz E, Dobson M. et al. Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial. Eur Respir J 2019; 54 (02) 1801550
43 Hayward SE, Rustage K, Nellums LB. et al. Extrapulmonary tuberculosis among migrants in Europe, 1995 to 2017. Clin Microbiol Infect 2021; 27 (09) 1347.e1-1347.e7
44 Macías A, Sánchez-Montalvá A, Salvador F. et al. Epidemiology and diagnosis of pleural tuberculosis in a low incidence country with high rate of immigrant population: a retrospective study. Int J Infect Dis 2019; 78: 34-38
45 Centers for Disease Control and Prevention. Reported Tubercolosis in the United States 2020. 2021 Accessed May 4, 2023 at: https://www.cdc.gov/tb/statistics/reports/2020/default.htm
46 Karstaedt AS. Extrapulmonary tuberculosis among adults: experience at Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa. S Afr Med J 2013; 104 (01) 22-24
47 Mlika-Cabanne N, Brauner M, Mugusi F. et al. Radiographic abnormalities in tuberculosis and risk of coexisting human immunodeficiency virus infection. Results from Dar-es-Salaam, Tanzania, and scoring system. Am J Respir Crit Care Med 1995; 152 (02) 786-793
48 Global TB Caucus. The Price of a Pandemic. 2017 . Accessed on November 1, 2022 at: https://docs.wixstatic.com/ugd/309c93_2709b6ff47c946fe97b94a72fdfd94e3.pdf
49 Silva S, Arinaminpathy N, Atun R, Goosby E, Reid M. Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis. Lancet Glob Health 2021; 9 (10) e1372-e1379
50 Centers for Disease Control and Prevention. CDC Estimates for TB Treatment Costs (in 2020 US Dollars). 2020 Accessed May 4, 2023 at: https://www.cdc.gov/tb/publications/infographic/appendix.htm
51 World Health Organization. The World Health Report 1998: report of the Director-General. 1998 Accessed May 4, 2023 at: https://apps.who.int/iris/handle/10665/42065
52 Centers for Disease Control and Prevention. Entamoeba histolytica Infection - Who is at risk for amebiasis?. 2021 Accessed May 4, 2023 at: https://www.cdc.gov/parasites/amebiasis/general-info.html
53 Stauffer W, Ravdin JI. Entamoeba histolytica: an update. Curr Opin Infect Dis 2003; 16 (05) 479-485
54 Centers for Disease Control and Prevention. Echinococcosis - Epidemiology & Risk Factors. 2012 Accessed May 4, 2023 at: https://www.cdc.gov/parasites/echinococcosis/epi.html
55 World Health Organization. Fact sheets – Echinococcosis. 2021 Accessed May 4, 2023 at: https://www.who.int/news-room/fact-sheets/detail/echinococcosis
56 Centers for Disease Control and Prevention. Paragonimiasis - Epidemiology & Risk Factors. 2013 Accessed May 4, 2023 at: https://www.cdc.gov/parasites/paragonimus/epi.html
57 Kim EA, Lee KS, Primack SL. et al. Viral pneumonias in adults: radiologic and pathologic findings. Radiographics 2002; 22 (Spec No): S137-S149
58 Nestor J, Huggins T, Kummerfeldt C, DiVietro M, Walters K, Sahn S. Viral diseases affecting the pleura. J Clin Virol 2013; 58 (02) 367-373
59 Koo HJ, Lim S, Choe J, Choi S-H, Sung H, Do K-H. Radiographic and CT features of viral pneumonia. Radiographics 2018; 38 (03) 719-739
60 Han BK, Son JA, Yoon HK, Lee SI. Epidemic adenoviral lower respiratory tract infection in pediatric patients: radiographic and clinical characteristics. AJR Am J Roentgenol 1998; 170 (04) 1077-1080
61 Arnold DT, Hamilton FW, Morris TT. et al. Epidemiology of pleural empyema in English hospitals and the impact of influenza. Eur Respir J 2021; 57 (06) 2003546
62 Chong WH, Saha BK, Conuel E, Chopra A. The incidence of pleural effusion in COVID-19 pneumonia: state-of-the-art review. Heart Lung 2021; 50 (04) 481-490
63 Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010. Thorax 2010; 65 (Suppl. 02) ii32-ii40
64 Pope III CA, Burnett RT, Thun MJ. et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002; 287 (09) 1132-1141
65 Hirata T, Yonemori K, Hirakawa A. et al. Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients. Eur Respir J 2011; 38 (06) 1425-1430
66 Taghizadeh N, Fortin M, Tremblay A. US hospitalizations for malignant pleural effusions: data from the 2012 National Inpatient Sample. Chest 2017; 151 (04) 845-854
67 Fortin M, Taghizadeh N, Tremblay A. Procedures performed during hospitalizations for malignant pleural effusions: data from the 2012 National Inpatient Sample. Respiration 2018; 95 (04) 228-234
68 Ost DE, Niu J, Zhao H, Grosu HB, Giordano SH. Quality gaps and comparative effectiveness of management strategies for recurrent malignant pleural effusions. Chest 2018; 153 (02) 438-452
69 Shafiq M, Ma X, Taghizadeh N. et al. Healthcare costs and utilization among patients hospitalized for malignant pleural effusion. Respiration 2020; 99 (03) 257-263
70 Tian P, Qiu R, Wang M. et al. Prevalence, causes, and health care burden of pleural effusions among hospitalized adults in China. JAMA Netw Open 2021; 4 (08) e2120306
71 Xia C, Dong X, Li H. et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl) 2022; 135 (05) 584-590
72 Botana-Rial M, Ramos-Hernández C, Lojo-Rodríguez I. et al. Cost effectiveness of malignant pleural effusion with indwelling catheter: systematic review. J Palliat Med 2021; 24 (08) 1206-1212
73 Olfert JAP, Penz ED, Manns BJ. et al. Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion. Respirology 2017; 22 (04) 764-770
74 Frank AL, Joshi TK. The global spread of asbestos. Ann Glob Health 2014; 80 (04) 257-262
75 Furuya S, Chimed-Ochir O, Takahashi K, David A, Takala J. Global asbestos disaster. Int J Environ Res Public Health 2018; 15 (05) 1000
76 World Health Organization. Fact sheets - Asbestos: Elimination of asbestos-related diseases. 2018 Accessed May 4, 2023 at: https://www.who.int/news-room/fact-sheets/detail/asbestos-elimination-of-asbestos-related-diseases
77 Mastrangelo G, Ballarin MN, Bellini E. et al. Feasibility of a screening programme for lung cancer in former asbestos workers. Occup Med (Lond) 2008; 58 (03) 175-180
78 Silva M, Sverzellati N, Colombi D. et al. Pleural plaques in lung cancer screening by low-dose computed tomography: prevalence, association with lung cancer and mortality. BMC Pulm Med 2017; 17 (01) 155
79 Naghavi M, Abajobir AA, Abbafati C. et al; GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390 (10100): 1151-1210
80 Chimed-Ochir O, Arachi D, Driscoll T, Lin R-T, Takala J, Takahashi K. Burden of mesothelioma deaths by national income category: current status and future implications. Int J Environ Res Public Health 2020; 17 (18) 6900
81 Borrelli E, Babcock Z, Kogut S. Costs of medical care for mesothelioma. Rare Tumors 2019; 11: 2036361319863498
82 Watterson A, Gorman T, Malcolm C, Robinson M, Beck M. The economic costs of health service treatments for asbestos-related mesothelioma deaths. Ann N Y Acad Sci 2006; 1076: 871-881
83 Tompa E, Kalcevich C, McLeod C. et al. The economic burden of lung cancer and mesothelioma due to occupational and para-occupational asbestos exposure. Occup Environ Med 2017; 74 (11) 816-822
84 Light RW, Macgregor MI, Luchsinger PC, Ball Jr WC. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77 (04) 507-513
85 Pocock SJ, Wang D, Pfeffer MA. et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006; 27 (01) 65-75
86 Morales-Rull JL, Bielsa S, Conde-Martel A. et al; RICA Investigators group. Pleural effusions in acute decompensated heart failure: prevalence and prognostic implications. Eur J Intern Med 2018; 52: 49-53
87 Kataoka H, Takada S. The role of thoracic ultrasonography for evaluation of patients with decompensated chronic heart failure. J Am Coll Cardiol 2000; 35 (06) 1638-1646
88 Ercan S, Davutoglu V, Altunbas G. et al. Prognostic role of incidental pleural effusion diagnosed during echocardiographic evaluation. Clin Cardiol 2014; 37 (02) 115-118
89 Devroey D, Van Casteren V. Symptoms and clinical signs associated with hospital admission and mortality for heart failure. Cent Eur J Public Health 2010; 18 (04) 209-214
90 Shetty S, Malik AH, Aronow WS, Alvarez P, Briasoulis A. Outcomes of thoracentesis for acute heart failure in hospitals. Am J Cardiol 2020; 125 (12) 1863-1869
91 Bramley K, DeBiasi E, Puchalski J. Indwelling pleural catheter placement for nonmalignant pleural effusions. Semin Respir Crit Care Med 2018; 39 (06) 713-719
92 Cheemerla S, Balakrishnan M. Global epidemiology of chronic liver disease. Clin Liver Dis (Hoboken) 2021; 17 (05) 365-370
93 Badillo R, Rockey DC. Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature. Medicine (Baltimore) 2014; 93 (03) 135-142
94 Castellote J, Gornals J, Lopez C, Xiol X. Acute tension hydrothorax: a life-threatening complication of cirrhosis. J Clin Gastroenterol 2002; 34 (05) 588-589
95 Shojaee S, Khalid M, Kallingal G, Kang L, Rahman N. Repeat thoracentesis in hepatic hydrothorax and non-hepatic hydrothorax effusions: a case-control study. Respiration 2018; 96 (04) 330-337
96 Kniese C, Diab K, Ghabril M, Bosslet G. Indwelling pleural catheters in hepatic hydrothorax: a single-center series of outcomes and complications. Chest 2019; 155 (02) 307-314
97 Shojaee S, Rahman N, Haas K. et al. Indwelling tunneled pleural catheters for refractory hepatic hydrothorax in patients with cirrhosis: a multicenter study. Chest 2019; 155 (03) 546-553
98 Chen A, Massoni J, Jung D, Crippin J. Indwelling tunneled pleural catheters for the management of hepatic hydrothorax. a pilot study. Ann Am Thorac Soc 2016; 13 (06) 862-866
99 Hsu S-L, Tseng C-W. Comparison of treatment of hepatic hydrothorax with catheter drainage versus serial thoracentesis. Curr Opin Pulm Med 2018; 24 (04) 392-397
100 Sobotka LA, Spitzer C, Hinton A. et al. Management of hepatic hydrothorax and effect on length of stay, mortality, cost, and 30-day hospital readmission. J Gastroenterol Hepatol 2020; 35 (04) 641-647
101 Jarratt MJ, Sahn SA. Pleural effusions in hospitalized patients receiving long-term hemodialysis. Chest 1995; 108 (02) 470-474
102 Bakirci T, Sasak G, Ozturk S, Akcay S, Sezer S, Haberal M. Pleural effusion in long-term hemodialysis patients. Transplant Proc 2007; 39 (04) 889-891
103 Potechin R, Amjadi K, Srour N. Indwelling pleural catheters for pleural effusions associated with end-stage renal disease: a case series. Ther Adv Respir Dis 2015; 9 (01) 22-27
104 Light RWMD. Pleural effusions. Med Clin North Am 2011; 95 (06) 1055-1070
105 Reddy S, Varaprasad K, Narahari N, Bhaskar K, Varma G, Paramjyothi G. Clinical and etiological profile of an exudative pleural effusion in a tertiary care center. Indian Journal of Respiratory Care 2019; 8: 22-26
106 Keane MP, Lynch III JP. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000; 55 (02) 159-166